
Opinion|Videos|April 21, 2025
Factoring Cost, Recommendations, and Evidence Into Formulary Decisions about Lp(a) Testing
Experts discuss the cost of lipoprotein(a) (Lp[a]) tests and how these costs, along with the National Lipid Association’s (NLA) recommendation and supporting clinical evidence, may influence payer decisions regarding coverage for Lp(a) testing.
Advertisement
Video content above is prompted by the following:
- How expensive are Lp(a) tests?
- How might these costs, the NLA’s recommendation, and the supporting clinical evidence factor into payer decisions about whether to cover Lp(a) testing?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Climate Change Will Affect Pulmonary Health Across Intensive Care
2
Reduction in Food Allergies Found After Guideline-Directed Early Peanut Exposure
3
Brensocatib Reduced Symptom Burden, Neutrophil Serine Proteases Activity in Bronchiectasis
4
Enfortumab Vedotin Plus Pembro Cuts Risk of Disease Progression, Death 60% for Patients With MIBC Who Can’t Have Chemo With Bladder Removal
5